Myocardial function, energy provision, and carnitine deficiency in experimental uremia

Journal of the American Society of Nephrology

Volumn 18, Issue 1, 2007, Pages 84-92

  Reddy, Veena ^a   Bhandari, Sunil ^b   Seymour, Anne Marie L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CREATININE; FATTY ACID; GLUCOSE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CARNITINE DEFICIENCY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; ENZYME SUBSTRATE; EXPERIMENTAL MODEL; HEART FUNCTION; HEART HYPERTROPHY; HEART MUSCLE METABOLISM; IN VITRO STUDY; MALE; MORTALITY; NEPHRECTOMY; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; UREMIA;

EID: 33846083137     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005080876     Document Type: Article

References (42)

1. US Renal Data System: 1999 Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999
2. Brunner F, Fassbinder W, Broyer M: Combined Report on Regular Dialysis and Transplantation in Europe, XVIII. London, Springer-Verlag, 1987, pp 5-32
3. Raine AE, Schwarz F, Ritz E: Hypertension and cardiac problems. In: Oxford Textbook of Clinical Nephrology, edited by Davison AM, Cameron S, Grunfeld J-P, Kerr DNS, Ritz E, Winearls CG, London, Oxford Medical Publications, 1998, pp 1885-1918
4. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32[Suppl 3]: S112-S119, 1998
5. Raine AE, Seymour AM, Roberts AF, Radda GK, Ledingham JG: Impairment of cardiac function and energetics in experimental renal failure. J Clin Invest 92: 2934-2940, 1993
6. Ronen SM, Raine AE, Yacoub M, Seymour A-ML: Recovery of PCr following Ischaemia Is Correlated with Hypertrophy in the Uraemic Heart [Abstract], New York, International Society for Magnetic Resonance in Medicine, 1996
7. Ogimoto G, Sakurada T, Imamura K, Kuboshima S, Maeba T, Kimura K, Owada S: Alteration of energy production by the heart in CRF patients undergoing peritoneal dialysis. Mol Cell Biochem 244: 135-138, 2003
8. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD: Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 267: H742-H750, 1994
9. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO: Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1213: 263-276, 1994
10. van der Vusse GJ, van Bilsen M, Glatz JF: Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 45: 279-293, 2000
11. Taegtmeyer H, Overturf ML: Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 11: 416-426, 1988
12. Christe ME, Rodgers RL: Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 26: 1371-1375, 1994
13. Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V: Carnitine and hemodialysis. Am J Kidney Dis 41[Suppl 1]: S116-S122, 2003
14. Schonekess BO, Lopaschuk GD: The effects of carnitine on myocardial carbohydrate metabolism. In: The Carnitine System: A New Therapeutical Approach to Cardiovascular Diseases, edited by De Jong JW, Ferrari R, Dordrecht, Kluwer Academic Publishers, 1995, pp 39-52
15. Martin MA, Gomez MA, Guillen F, Bornstein B, Campos Y, Rubio JC, de la Calzada CS, Arenas J: Myocardial carnitine and carnitine palmitoyltransferase deficiencies in patients with severe heart failure. Biochim Biophys Acta 1502: 330-336, 2000
16. Gamcsik MP, Forder JR, Millis KK: Communication to editor: A versatile oxygenator and perfusion system for magnetic resonance studies. Biotechnol Bioeng 348-354, 1996
17. Ogino H, Smolenski RT, Zych M, Seymour AM, Yacoub MH: Influence of preconditioning on rat heart subjected to prolonged cardioplegic arrest. Ann Thorac Surg 62: 469-474, 1996
18. Seymour A-M, Eldar H, Radda GK: Hyperthyroidism results in increased glycolytic capacity in the rat heart. A 31P-NMR study. Biochim Biophys Acta 1055: 107-116, 1990
19. Malloy CR, Sherry AD, Jeffrey FM: Analysis of tricarboxylic acid cycle of the heart using 13C isotope isomers. Am J Physiol 259: H987-H995, 1990
20. Smolenski R, Schrader J, de Groot H, Deussen A: Oxygen partial pressure and free intracellular adenosine of isolated cardiomyocytes. Am J Physiol 260: C708-C214, 1991
21. Chesser AMS: Myocardial Function in Experimental Uraemic Cardiomyopathy [doctoral thesis], London, University of London, 2004
22. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36[Suppl 3]: S24-S30, 2000
23. Gerdes AM: Cardiac myocyte remodelling in hypertrophy and progression to failure. J Card Fail 8[Suppl]: S264-S268, 2002
24. Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56-64, 1975
25. London GM: Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17[Suppl 1]: 29-36, 2002
26. Pascual J, Teruel JL, Moya JL, Liano F, Jimenez-Mena M, Ortuno J: Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study. Clin Nephrol 35: 280-287, 1991
27. Silberberg J, Racine N, Barre P, Sniderman AD: Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol 6: 1-4, 1990
28. De Vivo DC, Tein I: Primary and secondary disorders of carnitine metabolism. Int Paediatr 134-141, 1990
29. Wanner C, Horl WH: Carnitine abnormalities in patients with renal insufficiency. Pathophysiological and therapeutical aspects. Nephron 50: 89-102, 1988
30. Ferrari R, Di Mauro S, Sherwood G: L-carnitine and Its Role in Medicine: From Function to Therapy, London, Academic Press, 1992
31. Wanner C, Forstner-Warmer S, Rossle C, Furst P, Schollmeyer P, Horl WH: Carnitine metabolism in patients with chronic renal failure: Effect of L-carnitine supplementation. Kidney Int Suppl 32: S132-S135, 1987
32. Engel AG, Rebouche CJ: Carnitine metabolism and inborn errors. J Inherit Metab Dis 7[Suppl 1]: 38-43, 1984
33. Lloyd SG, Wang P, Zeng H, Chatham JC: Impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. Am J Physiol 287: H351-H362, 2004
34. Sample J, Cleland JGF, Seymour AL: Metabolic remodelling in the aging heart. J Mol Cell Cardiol 40: 56-63, 2006
35. El Alaoui-Talibi Z, Landormy S, Loireau A, Moravec J: Fatty acid oxidation and mechanical performance of volume-overloaded rat hearts. Am J Physiol 262: H1068-H1074, 1992
36. Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD, Recchia FA: Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 106: 606-612, 2002
37. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP: Fatty acid oxidation enzyme gene expression is down-regulated in the failing heart. Circulation 94: 2837-2842, 1996
38. Chandler MP, Kerner J, Huang H, Vazquez E, Reszko A, Martini WZ, Hoppel C, Imai M, Rastogi S, Sabbah HN, Stanley WC: Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol 287: H1538-H1543, 2004
39. Allard MF, Lopaschuk GD: Ischaemia and reperfusion injury in the hypertrophied heart. In: Myocardial Ischaemia: Mechanisms, Reperfusion, Protection, edited by Karmazyn M, Basel, Berkhauser Verlah, 1996, pp 432-452
40. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE: Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11: 1277-1285, 1996
41. Pehrsson SK, Jonasson R, Lins LE: Cardiac performance in various stages of renal failure. Br Heart J 52: 667-673, 1984
42. McMahon AC, Vescovo G, Dalla Libera L, Wynne DG, Fluck RJ, Harding SE, Raine AE: Contractile dysfunction of isolated ventricular myocytes in experimental uraemia. Exp Nephrol 4: 144-150, 1996